- Home
- VRDN vs CLM Comparison
VRDN vs CLM Comparison
Compare VRDN & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- CLM
- Stock Information
- Founded
- VRDN 2006
- CLM 1987
- Country
- VRDN United States
- CLM United States
- Employees
- VRDN N/A
- CLM N/A
- Industry
- VRDN Medical Specialities
- CLM Finance/Investors Services
- Sector
- VRDN Health Care
- CLM Finance
- Exchange
- VRDN Nasdaq
- CLM Nasdaq
- Market Cap
- VRDN 2.7B
- CLM 2.3B
- IPO Year
- VRDN N/A
- CLM N/A
- Fundamental
- Price
- VRDN $30.44
- CLM $8.08
- Analyst Decision
- VRDN Strong Buy
- CLM
- Analyst Count
- VRDN 11
- CLM 0
- Target Price
- VRDN $39.60
- CLM N/A
- AVG Volume (30 Days)
- VRDN 1.8M
- CLM 1.4M
- Earning Date
- VRDN 11-05-2025
- CLM 01-01-0001
- Dividend Yield
- VRDN N/A
- CLM 18.74%
- EPS Growth
- VRDN N/A
- CLM N/A
- EPS
- VRDN N/A
- CLM N/A
- Revenue
- VRDN $70,789,000.00
- CLM N/A
- Revenue This Year
- VRDN N/A
- CLM N/A
- Revenue Next Year
- VRDN $37,670.06
- CLM N/A
- P/E Ratio
- VRDN N/A
- CLM N/A
- Revenue Growth
- VRDN 23340.07
- CLM N/A
- 52 Week Low
- VRDN $9.90
- CLM $6.25
- 52 Week High
- VRDN $30.77
- CLM $8.84
- Technical
- Relative Strength Index (RSI)
- VRDN 77.12
- CLM 41.05
- Support Level
- VRDN $28.33
- CLM $8.03
- Resistance Level
- VRDN $29.58
- CLM $8.23
- Average True Range (ATR)
- VRDN 1.32
- CLM 0.10
- MACD
- VRDN 0.18
- CLM -0.02
- Stochastic Oscillator
- VRDN 95.37
- CLM 30.40
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.